Webinar April 7, 2020

FDA Update During the Coronavirus Pandemic

Event Detail
Cathy L. Burgess, Marc J. Scheineson, Brendan Carroll
April 7, 2020
1:00 PM - 2:00 PM Eastern Standard Time

The number of COVID-19 cases in the U.S. continues to rise, affecting employers and employees in every industry, from hospitality to manufacturing to health care. The FDA plays a critical role in combatting the spread of the coronavirus, and there have been many recent developments that affect FDA-regulated entities during the coronavirus pandemic.

This Alston & Bird webinar will review advice we are giving clients related to:

  • FDA inspection suspension and what that means for medical product manufacturers
  • COVID-19 impact on supply chain and recent FDA guidance
  • Emergency use authorizations regarding testing kits, drugs, PPEs, and ventilators
  • New FDA enforcement policies
  • Defense Production Act, hoarding prevention, and other FDA considerations

For more information, click here.

Media Contacts
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.